First Turn Management, LLC
Filing Date
Global Rank
#1,619
/ 8,232
▲ 156
Top Industry
Biotechnology
91.3%
3Y Alpha vs SPY
-13.3%
Period ended 2 months ago
Filed May 15, 2026 · 29d
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+16.2%
SPY
+52.9%
Annualised alpha
-13.3%
Max drawdown
−38.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
33 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
6.9%
+1.1 pts
Top 5
28.7%
+2.2 pts
Top 10
50.5%
+3.3 pts
HHI
381
Diversified+15
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $895,098,761 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | +363,426 | 2,256,109 | $17,304,356 | |
| QURE | uniQure N.V. | +293,834 | 615,489 | $10,063,245 | |
| VRDN | Viridian Therapeutics, Inc.DE | +220,809 | 911,337 | $17,825,751 | |
| OLMA | Olema Pharmaceuticals, Inc. | +150,948 | 768,662 | $11,460,750 | |
| IDYA | IDEAYA Biosciences, Inc. | +150,185 | 873,838 | $29,116,282 | |
| COGT | Cogent Biosciences, Inc. | +123,056 | 947,339 | $36,463,078 | |
| BBIO | BridgeBio Pharma, Inc. | +100,245 | 695,718 | $51,664,018 | |
| ABVX | Abivax S.A. | +84,636 | 465,869 | $51,874,513 | |
| MLTX | MoonLake Immunotherapeutics | +52,920 | 315,563 | $5,882,094 | |
| KYMR | Kymera Therapeutics, Inc. | +48,227 | 254,672 | $21,211,630 | |
| UTHR | UNITED THERAPEUTICS Corp | +41,146 | 104,726 | $62,100,423 | |
| APGE | Apogee Therapeutics, Inc. | +38,931 | 513,770 | $43,244,020 | |
| ORIC | Oric Pharmaceuticals, Inc. | +6,977 | 2,017,284 | $25,558,988 | |
| PRAX | Praxis Precision Medicines, Inc. | +6,692 | 42,441 | $13,674,065 | |
| ROIV | Roivant Sciences Ltd. | +3,301 | 1,190,118 | $32,966,268 | |
| NUVL | Nuvalent, Inc. | +1,647 | 370,344 | $37,941,742 | |
| NTRA | Natera, Inc. | +202 | 81,077 | $16,214,589 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | −545,355 | 326,694 | $17,223,307 | |
| NAMS | NewAmsterdam Pharma Co N.V. | −335,137 | 558,336 | $17,872,335 | |
| VERA | Vera Therapeutics, Inc. | −179,751 | 422,023 | $16,977,985 | |
| RVMD | Revolution Medicines, Inc. | −170,009 | 468,376 | $45,549,566 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −81,100 | 400,464 | $36,994,864 | |
| ASND | Ascendis Pharma A/S | −55,508 | 76,300 | $17,452,099 | |
| CYTK | Cytokinetics Inc | −41,968 | 283,700 | $18,698,667 | |
| AXSM | Axsome Therapeutics, Inc. | −18,149 | 188,772 | $31,906,243 | |
| INSM | INSMED Inc | −15,818 | 248,475 | $40,630,632 | |
| SRRK | Scholar Rock Holding Corp | −13,337 | 446,390 | $21,944,532 | |
| XENE | Xenon Pharmaceuticals Inc. | −12,899 | 786,844 | $45,754,978 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | 623,839 | $24,454,488 | |
| CELC | Celcuity Inc. | 210,578 | $24,035,372 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 220,921 | $18,539,690 | |
| PVLA | Palvella Therapeutics, Inc. | 148,093 | $18,459,792 | |
| ERAS | Erasca, Inc. | 867,639 | $14,038,399 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
5 positions
33 positions ·
$895,098,761 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 104,726 | $62,100,423 | 6.94% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 465,869 | $51,874,513 | 5.80% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 695,718 | $51,664,018 | 5.77% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 786,844 | $45,754,978 | 5.11% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 468,376 | $45,549,566 | 5.09% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 513,770 | $43,244,020 | 4.83% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 248,475 | $40,630,632 | 4.54% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 370,344 | $37,941,742 | 4.24% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 400,464 | $36,994,864 | 4.13% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 947,339 | $36,463,078 | 4.07% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 1,190,118 | $32,966,268 | 3.68% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 188,772 | $31,906,243 | 3.56% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Added | 873,838 | $29,116,282 | 3.25% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 2,017,284 | $25,558,988 | 2.86% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 623,839 | $24,454,488 | 2.73% | |
| CELC |
Celcuity Inc.
Healthcare
|
NEW | 210,578 | $24,035,372 | 2.69% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 446,390 | $21,944,532 | 2.45% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Added | 254,672 | $21,211,630 | 2.37% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 283,700 | $18,698,667 | 2.09% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
NEW | 220,921 | $18,539,690 | 2.07% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
NEW | 148,093 | $18,459,792 | 2.06% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 558,336 | $17,872,335 | 2.00% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Added | 911,337 | $17,825,751 | 1.99% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 76,300 | $17,452,099 | 1.95% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Added | 2,256,109 | $17,304,356 | 1.93% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 326,694 | $17,223,307 | 1.92% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 422,023 | $16,977,985 | 1.90% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 81,077 | $16,214,589 | 1.81% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 867,639 | $14,038,399 | 1.57% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 42,441 | $13,674,065 | 1.53% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Added | 768,662 | $11,460,750 | 1.28% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 615,489 | $10,063,245 | 1.12% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Added | 315,563 | $5,882,094 | 0.66% |